[Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma].


To evaluate the results of high-dose chemotherapy (HDT) and autologous hematopoietic stem cell transplantation (ASCT) in patients with diffuse B-cell aggressive non-Hodgkin's lymphoma(NHL). Between 1991 and 2004, 25 patients who did not achieve complete remission and 26 in complete remission from conventional chemotherapy received HDC-ASCT. Of 25 patients… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.